Investor Relations Corporate Profile Assembly Bio aspires to deliver innovative small molecule antiviral therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Minimum 15 minutes delayed. Source: LSEG Press Releases See all news Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026 Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights Events & Presentations See all upcoming events May 27 - May 30, 2026 European Association for the Study of the Liver (EASL) Congress 2026 May 13, 2026 at 4:35 PM PDT Bank of America Global Health Care Conference 2026 Apr 17 - Apr 21, 2026 Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Shareholder Tools Print Email Alerts RSS News Feeds Search Investors
Investor Relations Corporate Profile Assembly Bio aspires to deliver innovative small molecule antiviral therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Minimum 15 minutes delayed. Source: LSEG Press Releases See all news Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026 Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights Events & Presentations See all upcoming events May 27 - May 30, 2026 European Association for the Study of the Liver (EASL) Congress 2026 May 13, 2026 at 4:35 PM PDT Bank of America Global Health Care Conference 2026 Apr 17 - Apr 21, 2026 Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
